Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
The Lancet. Child & Adolescent Health|February 12, 2021
Real-time continuous glucose monitoring in preterm infants (REACT): an international, open-label, randomised controlled trialKathryn Beardsall, Lynn Thomson, Catherine Guy, et al.
BMJ Surgery, Interventions, & Health Technologies|January 20, 2022
Time to surgery following chronic subdural hematoma: post hoc analysis of a prospective cohort studySara Venturini, Daniel M Fountain, Laurence J Glancz, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 27, 2022
Effects of Exercise and Sleep Deprivation on Reaction Severity During Oral Peanut Challenge: A Randomized Controlled TrialShelley Dua, Monica Ruiz-Garcia, Simon Bond, et al.
Trials|July 10, 2020
Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 - Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trialSpoorthy Kulkarni, Marie Fisk, Michalis Kostapanos, et al.
BMJ Open|July 17, 2024
Study protocol for a randomised, phase II, double-blind, experimental medicine study of obinutuzumab versus rituximab in ANCA-associated vasculitis: ObiVasDominic Paul McGovern, Mark E McClure, Matthew Coates, et al.
Trials|August 2, 2020
muLTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19-Experimental drugs and mechanisms (TACTIC-E): A structured summary of a study protocol for a randomized controlled trialIng Ni Lu, Spoorthy Kulkarni, Marie Fisk, et al.
Journal of Crohn'S & Colitis|October 22, 2025
Anti-tumor necrosis factor treatment from diagnosis is more effective and less costly than conventional "step-up" care for patients with active Crohn's disease: a cost-effectiveness analysis from the PROFILE trialNurulamin M Noor, Neil Davies, Warda Tahir, et al.
BMJ Open|December 10, 2015
Protocol of the adaptive study of IL-2 dose frequency on regulatory T cells in type 1 diabetes (DILfrequency): a mechanistic, non-randomised, repeat dose, open-label, response-adaptive studyLucy A Truman, Marcin L Pekalski, Paula Kareclas, et al.
Clinical Kidney Journal|November 10, 2021
Developing a patient-centred tool for pain measurement and evaluation in autosomal dominant polycystic kidney diseaseRagada El-Damanawi, Michael Lee, Tess Harris, et al.
BMJ Open|February 18, 2019
Trial summary and protocol for a phase II randomised placebo-controlled double-blinded trial of Interleukin 1 blockade in Acute Severe Colitis: the IASO trialMartin Geoffrey Thomas, Carrie Bayliss, Simon Bond, et al.
Pageof 6